A phase 2 study of brentuximab vedotin in combination with pembrolizumab in subjects with metastatic solid malignancies
Details
Age
Adult
Type of Study
Treatment
Locations
University of Colorado Hospital
Principal Investigator
Laura Medina, MD
Study ID
Protocol Number: 20-2383
More information available at ClinicalTrials.gov: NCT04609566
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers